This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

McKesson Europe Past Earnings Performance

Past criteria checks 0/6

McKesson Europe's earnings have been declining at an average annual rate of -2039.3%, while the Healthcare industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 8.7% per year.

Key information

-2,039.3%

Earnings growth rate

-2,039.3%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate8.7%
Return on equity-2.0%
Net Margin-0.6%
Last Earnings Update31 Mar 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How McKesson Europe makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CAKF.Y Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 229,257-544500
31 Mar 218,51834840
31 Mar 2017,118-711,1460
31 Mar 1916,417-471,1590
31 Mar 1821,090-3031,4160
31 Mar 1720,644-8071,2600
31 Dec 1620,475-762,3330
30 Sep 1621,1184371,3540
30 Jun 1621,2654591,3870

Quality Earnings: CAKF.Y is currently unprofitable.

Growing Profit Margin: CAKF.Y is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if CAKF.Y's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare CAKF.Y's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CAKF.Y is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-10.4%).


Return on Equity

High ROE: CAKF.Y has a negative Return on Equity (-1.96%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies